106 related articles for article (PubMed ID: 10907360)
1. [Drugs stimulating insulin release. Importance of their use for improving glycemia, safety and quality of life in diabetes mellitus type 2].
Sieradzki J
Przegl Lek; 2000; 57(1):5-8. PubMed ID: 10907360
[TBL] [Abstract][Full Text] [Related]
2. [Molecular basis of oral hypoglycemic sulfonylurea action].
Owecki M; Horst-Sikorska W; Sowiński J
Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
[TBL] [Abstract][Full Text] [Related]
3. [The role of sulphonylurea derivatives in treatment of diabetes type 2. The role of glimepiride].
Sieradzki J
Przegl Lek; 2000; 57 Suppl 4():13-8. PubMed ID: 11293224
[TBL] [Abstract][Full Text] [Related]
4. Treating diabetes today: a matter of selectivity of sulphonylureas.
Seino S; Takahashi H; Takahashi T; Shibasaki T
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():9-13. PubMed ID: 22118705
[TBL] [Abstract][Full Text] [Related]
5. Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Abdelmoneim AS; Hasenbank SE; Seubert JM; Brocks DR; Light PE; Simpson SH
Diabetes Obes Metab; 2012 Feb; 14(2):130-8. PubMed ID: 21923736
[TBL] [Abstract][Full Text] [Related]
6. [Sulfonylurea drugs for type 2 diabetes].
Toyota T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
[No Abstract] [Full Text] [Related]
7. [Sulfonylurea receptors and their interaction with glimepiride].
Zueva NA; Sologub NV; Efimov AS
Lik Sprava; 2003; (2):35-9. PubMed ID: 12774471
[TBL] [Abstract][Full Text] [Related]
8. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
Sperling MA
N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
[No Abstract] [Full Text] [Related]
9. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
Meirhaeghe A; Helbecque N; Cottel D; Arveiler D; Ruidavets JB; Haas B; Ferrières J; Tauber JP; Bingham A; Amouyel P
Am J Med Genet; 2001 Jun; 101(1):4-8. PubMed ID: 11343328
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
Zychma MJ; Gumprecht J; Strojek K; Grzeszczak W; Moczulski D; Trautsolt W; Karasek D
Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the glycaemic effects of sulfonylureas.
Ashcroft FM
Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983
[TBL] [Abstract][Full Text] [Related]
12. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
[TBL] [Abstract][Full Text] [Related]
13. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics of insulin secretagogue antidiabetics].
Winkler G; Gerô L
Orv Hetil; 2011 Oct; 152(41):1651-60. PubMed ID: 21959939
[TBL] [Abstract][Full Text] [Related]
15. [The sulfonylurea receptor].
Inagaki N; Gonoi T; Seino S
Seikagaku; 1997 Sep; 69(9):1067-80. PubMed ID: 9364874
[No Abstract] [Full Text] [Related]
16. [A rapid- and short-acting insulinotropic agent KAD-1229].
Komatsu H; Ohnota H; Koizumi T; Satoh F
Nihon Rinsho; 1997 Nov; 55 Suppl():171-9. PubMed ID: 9434463
[No Abstract] [Full Text] [Related]
17. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea signal transduction.
Boyd AE; Aguilar-Bryan L; Bryan J; Kunze DL; Moss L; Nelson DA; Rajan AS; Raef H; Xiang HD; Yaney GC
Recent Prog Horm Res; 1991; 47():299-316; discussion 316-7. PubMed ID: 1660613
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J
Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
[TBL] [Abstract][Full Text] [Related]
20. Gliclazide modified release: from once-daily administration to 24-hour blood glucose control.
Harrower A
Metabolism; 2000 Oct; 49(10 Suppl 2):7-11. PubMed ID: 11078469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
